Role Overview
The Director, Commercial Strategy & Business Development Assessment is responsible for supporting U.S. commercial assessments, commercialization planning, strategic evaluations, policy assessments, and integration planning activities for external business development opportunities and internal portfolio expansion initiatives.
What You Will Do
Lead U.S. commercial assessments for acquisition, licensing, partnership and strategic business development opportunities. Evaluate strategic fit, unmet need, treatment paradigms, competitive intensity, market attractiveness and long-term commercial potential.
Why It Might Be a Fit
Exceptional commercial acumen and strategic thinking capabilities. Strong understanding of pharmaceutical pricing, reimbursement, market access, commercialization and portfolio evaluation principles.
Requirements
Bachelor’s degree required.
8-10+ years of progressive pharmaceutical, biotechnology, healthcare consulting, commercial strategy, commercial development, market access, portfolio strategy or business development experience.
Experience conducting commercial due diligence, portfolio assessments, strategic business analyses or asset evaluations.
Specialty pharmaceutical or biotechnology experience required.
Rare disease experience strongly preferred. Benefits
Competitive 401(k) match
Tuition and wellness reimbursements
Comprehensive medical, dental, and vision package
Additional recognition awards
Sobi is a specialty pharmaceutical company focused on improving the lives of people living with rare and orphan diseases, particularly those affecting metabolism and lipid disorders. The company specializes in the development and commercialization of treatments for conditions such as FSC (Familial Chylomicronemia Syndrome) and sTGH (Severe Triglyceridemia), with a mission centered on patient-centric care and appropriate disease identification. Sobi operates internationally with a strong emphasis on cross-regional collaboration, leveraging digital engagement, medical affairs expertise, and market access strategies to ensure timely patient diagnosis and treatment adoption. The company integrates scientific insights with commercial execution to create scalable frameworks and omnichannel engagement approaches for healthcare providers, payers, and patient organizations.
